How the Driverless Car Could Transform Older Adults’ Lives

The dawn of the driverless car promises a transportation revolution. Advocates claim this will change lives as radically as the Internet changed communication. But there are speed bumps ahead. Whether the growing population of older adults will fully realize the benefits remains a question subject to many moving parts.

With populations aging across the world and 10,000 U.S. baby boomers turning 65 every day, maximizing the potential of driverless technology for older adults should be an obvious priority.

There could be no more uncomfortable conversations about taking the keys away from aging parents suffering from vision, memory or physical challenges. With the majority of older adults seeking to age in place and remain independent and self-sufficient as long as possible, the loss of a driver’s license wouldn’t mean the end of mobility and a contracting life. Disconnected retirees could reconnect. New opportunities for work and volunteer activities could flourish. Access to health providers could improve.

And the benefits could spread. With reduced dependency, caregiving family members could have more freedom to attend to life’s other demands. Young people could profit from more intergenerational engagement.

It all sounds wonderful. We just have to make sure we get from here to there.

One potential roadblock: Although aging baby boomers are more technology friendly than their silent generation forebears, older adults have generally been later adopters of technologies than their younger counterparts. What’s more, wealthier and more educated individuals are more positive about the benefits of technology than those less affluent, according to Pew Research Center.

This could mean that the older adults who might benefit most from driverless cars, including a large number dealing with isolation, financial stress and health challenges, may be left on the side of the road.

The message? Planners must act now to ensure a successful transition to driverless cars for all.

Mobile phones, call devices and apps must be re-imagined to engage users and to overcome resistance and the physical challenges of aging. Age-friendly homes, sidewalks, streets and communities must optimize the utility of driverless cars. Passengers must comfortably and safely get from the front door to their vehicle and from their vehicle to their ultimate destination.

Realizing the opportunities also requires social innovations to match this potentially transformational technology.

With the additional mobility, older adults will have a chance to become involved in their communities in new ways. Many will want to pursue work and volunteer opportunities and they’ll need public and private institutions to recognize their potential for productivity. With universities and colleges in easier reach, they’ll need welcoming environments where they can enhance their skills and knowledge. With freedom to move, they’ll want shopping, dining and cultural venues that are attuned to their tastes and sensitive to their needs. They’ll require help to become technologically literate–to know the questions to ask and the resources available to navigate a changing environment.

The driverless revolution must be about more than innovative technology; it must be about change at a system-level. By planning with the aging population in mind, re-envisioning communities, and shifting attitudes about the value of older adults, we’ll ensure that driverless cars put people of all ages on the road to a better future.

Paul Irving is chairman of the Center for the Future of Aging at the Milken Institute and distinguished scholar in residence at the University of Southern California Davis School of Gerontology.

Source: Wall Street Journal

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.